Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer | BMC Cancer | Full Text

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer | BMC Cancer | Full Text

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor. Currently, therapeutic methods for this patient population include whole-brain radiation therapy (WBRT), surgery, radiosu...

Authors:Kejun Liu, Guanming Jiang, Ailing Zhang, Zhuanghua Li and Jun Jia

Citation:BMC Cancer 2020 20:76

Content type:Research article

Published on: 30 January 2020

• ViewFull Text
 
• ViewPDF